Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120230725A reveals high-selectivity monooxygenase mutants for statin synthesis. Enables cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112176011B reveals a papain-catalyzed route for valacyclovir hydrochloride. This green method eliminates palladium catalysts, offering significant cost reduction and supply chain stability for API manufacturers.
Patent CN102618513B details a robust biocatalytic route for API intermediates, offering high ee values and scalability without expensive cofactors.
Patent CN109180691B reveals an enzymatic route for C3-aromatic pyrroloindole alkaloids. This method offers high optical purity and scalable production for neuroprotective drug development.
Patent CN118389613A reveals high-yield hydroxytyrosol synthesis. Offers cost reduction and supply chain reliability for food and pharma industries.
Patent CN101565685A reveals a novel recombinant E. coli strain for producing chiral acetoin and 2,3-butanediol with high ee values, offering significant cost reduction in chiral chemical manufacturing.
Patent CN116179502A details a novel ketoreductase mutant enabling >99% ee chiral alcohol synthesis. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patent CN104131048A reveals high-yield biological synthesis for chiral intermediates. Achieve superior purity and cost efficiency in pharmaceutical manufacturing supply chains.
Patent CN100376681C details a microbial asymmetric reduction method for (R)-mandelic acid using Saccharomyces cerevisiae, offering a green, cost-effective alternative to traditional chemical resolution for pharmaceutical manufacturing.
Patent CN113881720B reveals enzymatic synthesis for high-purity intermediates. Achieve cost reduction and supply chain reliability with scalable biocatalysis.
Patent CN103276025A details a high-purity enzymatic route for L-heterocyclic amino acids, offering significant cost and supply chain advantages for API manufacturing.
Patent CN115537405B reveals a high-efficiency ketoreductase mutant for producing chiral pharmaceutical intermediates with superior selectivity and scalable manufacturing potential.
Patent CN107201355B details a novel phenylalanine deaminase mutant enabling cost-effective, high-purity D-phenylalanine production via single-step enzymatic catalysis.
Patent CN119614533B reveals thermostable enzyme mutants improving R-chiral amine synthesis efficiency and supply chain stability for pharmaceutical intermediates.
Patent CN110577941B details mutated amine dehydrogenase for asymmetric reductive amination, offering high optical purity and scalable biocatalysis for pharmaceutical intermediates.
Patent CN114958938B reveals enzymatic synthesis for Paxlovid intermediate. Offers high yield and cost reduction for pharmaceutical intermediate supply chains.
Patent CN112608970A reveals water-based biotransformation for methylprednisolone. Enhances conversion rates and supply chain reliability for pharmaceutical intermediates.
Patent CN101760495B reveals a bio-dehydrogenation method for steroid intermediates. Achieve higher yields and eliminate toxic selenium residues for cost-effective manufacturing.
Patent CN106520896B reveals one-step fermentation for 8DM. Enhances yield and reduces solvent use for reliable pharmaceutical intermediates supply chains.
Novel MOF-immobilized lipase catalyst enables green, high-yield production of Benzyl Carbazate. Ideal for Indoxacarb synthesis. Reliable supply chain partner.